0001179110-19-010082.txt : 20190904 0001179110-19-010082.hdr.sgml : 20190904 20190904170544 ACCESSION NUMBER: 0001179110-19-010082 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190830 FILED AS OF DATE: 20190904 DATE AS OF CHANGE: 20190904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goss Michael L CENTRAL INDEX KEY: 0001783472 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36269 FILM NUMBER: 191075332 MAIL ADDRESS: STREET 1: 77 FOURTH AVE., 5TH FLOOR CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Care.com Inc CENTRAL INDEX KEY: 0001412270 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PERSONAL SERVICES [7200] IRS NUMBER: 205785879 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 77 FOURTH AVENUE STREET 2: 5TH FLOOR CITY: Waltham STATE: MA ZIP: 02451 BUSINESS PHONE: 781 642 5900 MAIL ADDRESS: STREET 1: 77 FOURTH AVENUE STREET 2: 5TH FLOOR CITY: Waltham STATE: MA ZIP: 02451 3 1 edgar.xml FORM 3 - X0206 3 2019-08-30 0 0001412270 Care.com Inc CRCM 0001783472 Goss Michael L C/O CARE.COM, INC. 77 FOURTH AVENUE, 5TH FLOOR WALTHAM MA 02451 0 1 0 0 Acting Chief Financial Officer Common Stock, $0.001 par value 3161 D Restricted Stock Units Common Stock 1399 D Restricted Stock Units Common Stock 2114 D Restricted Stock Units Common Stock 915 D Restricted Stock Units Common Stock 2889 D Restricted Stock Units Common Stock 634 D Restricted Stock Units Common Stock 4020 D Options (Right to Buy) 6.70 Common Stock 5832 D Options (Right to Buy) 12.01 Common Stock 6334 D The restricted stock units will vest as to 6.25% of the original grant on June 9, 2016 and at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will vest as to 6.25% of the original grant on June 9, 2017 and at the end of each successive three month period thereafter until March 9, 2021, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date. The restricted stock units will vest as to 33.33% of the original grant on February 26, 2018 and as to an additional 16.67% at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date. The restricted stock units will vest as to 6.25% of the original grant on June 9, 2018 and at the end of each successive three month period thereafter until March 9, 2022, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date. The restricted stock units will vest as to 50% of the original grant on March 9, 2019 and as to an additional 12.5% at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date. The restricted stock units will vest as to 6.25% of the original grant on June 9, 2019 and at the end of each successive three month period thereafter until March 9, 2023, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date. The options will vest as to 6.25% of the original grant on June 9, 2016 and at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The options will expire on March 10, 2026. The options will vest as to 6.25% of the original grant on June 9, 2017 and at the end of each successive three month period thereafter until March 9, 2021, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The options will expire on March 15, 2027. /s/ Melanie Goins, as Attorney-in-Fact for Michael Goss 2019-09-04